BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34149623)

  • 1. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM; Schalin-Jäntti C; Matikainen N
    Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
    Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
    Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
    Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
    Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
    Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
    Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
    Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
    J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.
    Mishra D; Kaur H; Bhalla AS; Manchanda S; Sasikumar J; Agarwal B; Roychoudhury A
    Head Neck Pathol; 2021 Sep; 15(3):975-988. PubMed ID: 33394371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
    Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
    Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report.
    Oe Y; Kameda H; Nomoto H; Sakamoto K; Soyama T; Cho KY; Nakamura A; Iwasaki K; Abo D; Kudo K; Miyoshi H; Atsumi T
    Medicine (Baltimore); 2021 Nov; 100(46):e27895. PubMed ID: 34797338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.
    Lin HA; Shih SR; Tseng YT; Chen CH; Chiu WY; Hsu CY; Tsai KS
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4403-7. PubMed ID: 25181387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.